CancerenD24 Screening as an Aid to the Clinician for the Diagnosis of Cancer

Launched by TEL-AVIV SOURASKY MEDICAL CENTER · Oct 23, 2024

Keywords

ClinConnect Summary

This clinical trial, called CancerenD24, is designed to see if a special test can help doctors find cancer earlier in people who are currently healthy. The test uses an algorithm, which is a step-by-step method, to analyze certain markers in the blood and other health information to identify signs of cancer. By participating, you could help researchers learn more about early cancer detection, which is crucial for successful treatment.

To be eligible for this study, participants must be at least 40 years old and willing to complete some medical exams and questionnaires. Unfortunately, people under 40, those who are pregnant or breastfeeding, or anyone with a recent fever or certain medical conditions like active cancer or inflammatory bowel disease cannot participate. If you join the study, you can expect to provide information about your health and undergo a few tests, all while helping to advance cancer research.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Completion of all medical exams and questionnaires including cancer diagnoses, demographic data and other epidemiologic information
• • 2. Willing and able to sign an informed consent
• • 3. Age ≥40 years
• Exclusion Criteria:
• • 1. Age \< 40 years
• • 2. Pregnancy or breastfeeding
• • 3. Any type of fever
• • 4. Any cancer active at study entry or up to 5 years prior to study entry
• • 5. Polyposis syndromes
• • 6. Inflammatory bowel disease
• • 7. Unwilling or unable to provide informed consent